When.com Web Search

  1. Ads

    related to: myasthenia gravis remission after thymectomy infection update
    • FAQ

      Get Answers To Your Questions.

      Learn More On The Official Site!

    • Resources

      Review Helpful Information About

      Generalized Myasthenia Gravis.

Search results

  1. Results From The WOW.Com Content Network
  2. Myasthenia gravis - Wikipedia

    en.wikipedia.org/wiki/Myasthenia_gravis

    Myasthenia gravis (MG) is a long-term neuromuscular junction disease that leads to varying degrees of skeletal muscle weakness. [1] The most commonly affected muscles are those of the eyes, face, and swallowing. [1][5] It can result in double vision, drooping eyelids, and difficulties in talking and walking. [1]

  3. Thymectomy - Wikipedia

    en.wikipedia.org/wiki/Thymectomy

    Thymectomy is a treatment for myasthenia gravis, a neuromuscular disease. [5] For about 60% of people with myasthenia gravis, thymectomy significantly improves their symptoms of muscle weakness. In about 30% of cases, thymectomy results in permanent remission of myasthenia gravis, negating the need for any additional medication.

  4. Thymoma - Wikipedia

    en.wikipedia.org/wiki/Thymoma

    Thymoma. surgical removal, chemotherapy (in malignant cases). A thymoma is a tumor originating from the epithelial cells of the thymus that is considered a rare neoplasm. [1] Thymomas are frequently associated with neuromuscular disorders such as myasthenia gravis; [2] thymoma is found in 20% of patients with myasthenia gravis. [3]

  5. Lambert–Eaton myasthenic syndrome - Wikipedia

    en.wikipedia.org/wiki/Lambert–Eaton_myasthenic...

    Myasthenia gravis is caused by autoantibodies to the postsynaptic acetylcholine receptors. Lambert–Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder characterized by muscle weakness of the limbs. It is also known as myasthenic syndrome, Eaton–Lambert syndrome, and when related to cancer, carcinomatous myopathy.

  6. Amgen's muscular disorder drug meets main goal in late-stage ...

    www.aol.com/news/amgens-muscular-disorder-drug...

    Engagement with regulatory bodies for Uplizna is underway for use in myasthenia gravis patients and for another immune system-related condition, said Amgen's chief scientific officer James Bradner ...

  7. Mary Broadfoot Walker - Wikipedia

    en.wikipedia.org/wiki/Mary_Broadfoot_Walker

    Awards. Royal College of Physicians Jean Hunter Prize (1962) Mary Broadfoot Walker (17 April 1888 – 13 September 1974) was a Scottish physician who first demonstrated the effectiveness of physostigmine in the treatment of the condition myasthenia gravis, a disease relating to muscle weakness. She was also the first to recognise the ...

  1. Ads

    related to: myasthenia gravis remission after thymectomy infection update